Loading clinical trials...
Loading clinical trials...
Comparison of Thromboembolic Events in Patients Undergoing Gastrointestinal Cancer Surgery and Thromboprophylactic Treatment With Two Enoxaparin Formulations (ENOXA® vs Lovenox®)
Conditions
Interventions
Enoxaparin 4000 IU
Locations
1
Tunisia
Charles Nicolle Hospital
Tunis, Tunis BAB Souika, Tunisia
Start Date
October 1, 2015
Primary Completion Date
July 1, 2020
Completion Date
July 10, 2020
Last Updated
July 29, 2021
NCT06663319
NCT01750619
NCT06048146
NCT05551052
NCT07372716
NCT07389525
Lead Sponsor
Les Laboratoires des Médicaments Stériles
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions